Ostéoporose chez les femmes ménopausées entre 40 et 65 ans : algorithme pour le gynécologue [Osteoporosis in menopausal women between 40 and 65 years old : an algorithm for the gynaecologist]

Details

Serval ID
serval:BIB_68868F1117FE
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Title
Ostéoporose chez les femmes ménopausées entre 40 et 65 ans : algorithme pour le gynécologue [Osteoporosis in menopausal women between 40 and 65 years old : an algorithm for the gynaecologist]
Journal
Revue medicale suisse
Author(s)
Surbone A., Vulliemoz N., Gonzalez-Rodriguez E., Chatelain J.P., Lamy O.
ISSN
1660-9379 (Print)
ISSN-L
1660-9379
Publication state
Published
Issued date
26/10/2016
Peer-reviewed
Oui
Volume
12
Number
536
Pages
1811-1815
Language
french
Notes
Publication types: Journal Article
Publication Status: ppublish
Abstract
Osteoporosis is a bone disease that promotes the development of fragility fractures. An algorithm is proposed for the gynaecologists'use to diagnose and treat osteoporosis in young menopausal women. The fracture risk can be calculated with the FRAX tool. If the 10-year fracture risk is ≥ 10 %, a bone densitometry is recommended, and the result is integrated in the FRAX tool. If the risk is between 10 and 20 %, a treatment should be discussed individually and, in some cases, a pharmacologic preventive treatment, by menopause hormonal treatment or SERMs, can be initiated. A pharmacologic treatment (bisphosphonates or dénosumab) is recommended in case of previous fragility fracture or risk ≥ 20 %, independently of a T-score < -2.5 DS. Patients have to be referred in case of treatment failure or intolerance, and at the end of any denosumab therapy.

Keywords
Adult, Aged, Algorithms, Bone Density Conservation Agents/therapeutic use, Denosumab/therapeutic use, Diphosphonates/therapeutic use, Female, Gynecology/methods, Humans, Menopause, Middle Aged, Osteoporosis, Postmenopausal/complications, Osteoporosis, Postmenopausal/drug therapy, Osteoporotic Fractures/prevention & control, Risk Assessment/methods
Pubmed
Create date
03/08/2017 14:11
Last modification date
07/10/2019 8:10
Usage data